Skip to content

Medpace Voice

Tag: COVID-19

Clinical Development

[Presentation] How the COVID-19 Pandemic Impacted Clinical Development from an Operations Perspective

  • July 7, 2021

Medpace’s Director of Clinical Trial Management, Alex Krutilin, took the virtual stage at the Outsourcing in Clinical Trials UK & Ireland conference to discuss how…

Clinical Development

A New Paradigm in Infectious Diseases Treatment & Prophylaxis Shaped by the Current Pandemic

  • June 2, 2021

The COVID-19 pandemic will end, or as any pandemic in the past, will lose its momentum. Yet, the precedents and the new paradigms formed in…

Clinical Development

Medpace Clinical Pharmacology Unit working with HiFiBIO Therapeutics on a SARS-CoV-2 ID-neutralizing antibody for the treatment and prevention of COV19

  • October 29, 2020

In a recent news release, HiFiBiO Therapeutics announced the successful completion of the first cohort of the Phase I study (NCT04590430) of HFB30132 which was…


Working at Medpace During COVID-19

  • October 6, 2020

While COVID-19 has had many effects on how we run our clinical trials as we continue to provide essential services during the pandemic, we’ve also…

Clinical Development

COVID-19 Webinars – Medpace Assembles Team of Experts to Discuss Considerations for Future SARS-CoV-2 Development

  • May 18, 2020

In these upcoming webinars, experts from Medpace’s medical department, regulatory, and operational teams will provide insights and considerations on how to accelerate product development for…

Central Laboratories

Minimizing Disruption to Clinical Trials During COVID-19

  • April 16, 2020

Medpace is committed to keeping Sponsors on PACE to maintain regular activity during this irregular time.

Central Laboratories

COVID-19 Laboratory Testing: Medpace Central Labs

  • April 6, 2020

To serve our Sponsors in their COVID-19 programs, Medpace has expedited COVID-19 assay validations to meet clinical trial testing standards.